购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • JAK
    (1)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 6-8周
    (1)
  • 10-14周
    (1)
筛选
搜索结果
TargetMol产品目录中 "

incb 39110

"的结果
  • 抑制剂&激动剂
    3
    TargetMol | Inhibitors_Agonists
  • INCB-39110
    T703101651228-00-0
    INCB-39110 is a JAK1 inhibitor.
    • ¥ 10600
    6-8周
    规格
    数量
  • Itacitinib
    伊他替尼, INCB39110, INCB039110
    T39981334298-90-6
    Itacitinib (INCB039110) 是一种选择性 JAK1抑制剂,对 人JAK1的IC50值为 2 nM。它对JAK1选择性是 JAK2 的 20 倍多,是 JAK3 和 TYK2 的 100 倍多。
    • ¥ 395
    现货
    规格
    数量
    TargetMol | Inhibitor Hot
  • Dicetrorelix pamoate
    T70309165186-69-6
    Dicetrorelix pamoate is a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity. GnRH induces the production and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the gonadotrophic cells of the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH liberation is enhanced resulting in an LH-surge. This LH-surge induces the ovulation of the dominant follicle, resumption of oocyte meiosis and subsequently luteinization as indicated by rising progesterone levels. Cetrorelix competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner. Cetrorelix binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion. It competes with natural GnRH for binding to membrane receptors on pituitary cells and thus controls the release of LH and FSH in a dose-dependent manner......
    • ¥ 17200
    10-14周
    规格
    数量